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Colostomy for Perianal Sepsis With Ecthyma Gangrenosum
in Immunocompromised Children
Raphael N. Vuille-dit-Bille, MD, PhD,*w Christoph Berger, MD,wz
Martin Meuli, MD,*w and Michael A. Grotzer, MDwy
Background: Perianal sepsis with ecthyma gangrenosum is a severe
and potentially mutilating complication in immunocompromised
children. Therapies include antimicrobial treatment, incision and
drainage, generous tissue debridement, and skin transplantation.
Procedure: We describe 3 children with acute lymphoblastic leu-
kemia having sepsis with Pseudomonas aeruginosa in febrile neu-
tropenia and severe perianal infections treated relatively early with
a protective colostomy. Indications for colostomy were nonhealing
wounds, and ceaseless pain.
Results: All patients showed a rapid reduction of pain. Complete
wound healing was seen in 2 patients, and considerable pain
reduction and increased quality of life were seen in a third patient
during palliative care.
Conclusions: These results suggest that a protective colostomy
should be considered early in the management of immunocom-
promised children with ecthyma gangrenosum.
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(J Pediatr Hematol Oncol 2015;00:000–000)
Perianal sepsis is a life-threatening and potentially muti-lating complication in patients with acute leukemia and
other malignancies, which occurs either at the onset of
disease or as an adverse eﬀect of chemotherapy.1 Neu-
tropenia represents a signiﬁcant prognostic factor for
infections in immunocompromised patients2 and for per-
ianal sepsis in particular. The gram-negative bacterium
Pseudomonas aeruginosa (PSA) is a common pathogen that
may cause severe opportunistic infections invading the skin,
the subcutaneous fat layer, as well as mucus membranes of
immunocompromised children. The perianal region and the
axilla are particularly prone to pseudomonas-related skin
infections.3 Skin lesions at the perianal region may have
serious consequences, including skin and soft-tissue
necrosis including the sphincter apparatus. The latter may
lead to lifelong incontinence. Treatment approaches include
antimicrobial therapy, incision, vigorous tissue debride-
ment, and skin transplantations.4
Temporary colostomy may be used to keep stool out
of the area of the colon and skin that is inﬂamed, infected,
diseased, or newly operated on—this allows healing to take
place. However, to the best of our knowledge, this
approach has been reported so far in only 2 case series of
perianal sepsis in immunocompromised children.1,4
Whether to perform a diverting colostomy is controversial,
and evidence concerning indication and appropriate timing
for local surgery as well as for colostomy type is lacking.
The aim of the present study was to analyze the out-
come after performing a diversion colostomy in 3 immu-
nocompromised children with perianal sepsis and ecthyma
gangrenosum (EG) as well as to review the literature.
PATIENTS AND METHODS
We describe 3 male patients aged 3.3 to 4.8 years with
acute lymphoblastic leukemia suﬀering from PSA sepsis,
febrile neutropenia, and severe perianal, ulcerative infec-
tions treated with a protective colostomy between January
2011 and December 2013 at the University Children’s
Hospital of Zurich, Switzerland (Table 1). All patients had
neutropenia with an absolute neutrophil count <0.5 g/L
when a perianal lesion was ﬁrst noted.
Case 1
A boy aged 3.3 years diagnosed with acute T-cell lympho-
blastic leukemia (T-ALL) presented 4 months after the initiation of
chemotherapy (AIEOP-BFM ALL 2009 trial protocol) with febrile
neutropenia, oral mucositis, and painful defecation. The evaluation
revealed pseudomonas sepsis. On physical examination, he showed
a perianal and endoanal dark red swelling that displayed the typical
clinical features and hallmarks of EG (Fig. 1A). Antimicrobial
treatment was initiated with ceftazidime for 23 days, combined
with ciproﬂoxacin for the ﬁrst 10 days, as the isolate from the blood
culture was resistant to gentamicin and showed only intermediate
susceptibility against meropenem. Analgetic treatment consisted of
fentanyl and acetaminophen. After 16 days, a ﬁrst local debride-
ment had to be performed and endoanal negative-pressure wound
therapy using the VAC system was established (Fig. 1B). A second
debridement followed 3 days later. The boy had regular passage of
stool (4 to 5 times a day) under therapy with lactulose. Eventually,
after another 4 days, because of a massive progression of the per-
ianal lesion, a dismembered colostomy (Fig. 1C) was performed to
prevent stool passage and to allow anterograde enemas. The
patient’s postoperative course was uncomplicated, and regular
enemas could be performed easily without anesthesia. Chemo-
therapy was reinstalled 5 days after surgery; 1 day later, the patient
was discharged from the hospital in good clinical condition, with a
clean, granulating perianal wound. The patient showed progressive
perianal healing (Fig. 1D) and no stoma-related complications
were present. The reversal of the colostomy was uneventfully per-
formed 9 months later. Defecation is normal.
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Case 2
A boy aged 4.3 years was transferred from a peripheral
hospital to our center after presenting with pancytopenia (hemo-
globin level, 7.1 g/L; white blood cell count, 0.8 g/L; neutrophil
count, 0.4 g/L; platelet count, 57,000 g/L), fever, severe oral and
anal mucositis, and a perianal skin lesion. At presentation to our
institution, the patient had fever, oral and anal mucositis, con-
stipation, pain, reduced oral food intake, and hypokalemia. The
cultures from blood drawn 6 days before referral were positive for
PSA, as were the oral and the perianal wound cultures on admis-
sion. Empiric antimicrobial therapy with meropenem, conﬁrmed to
be eﬃcient by antimicrobial susceptibility testing, was administered
for 3 weeks in total. Analgetic treatment consisted of fentanyl,
acetaminophen, and metamizole. Bone marrow examination con-
ﬁrmed the suspected diagnosis of ALL, and chemotherapy
(AIEOP-BFM ALL 2009) was initiated. Five days after admission,
the ﬁrst surgical debridement was performed, revealing a deep anal
ulceration with partial involvement of the external anal sphincter.
A second debridement performed 16 days later revealed progressive
sphincter destruction. Therefore, a protective nondiverting double-
barrel sigmoid colostomy was performed 1 day later to avoid the
passage of stool, to reduce bacterial load at the wound site, and to
promote wound healing. The postoperative course was uncompli-
cated, and the patient was discharged 7 days after surgery in good
condition. In regular clinical controls, the patient showed complete
healing of the perianal region within 7 days along with regular anal
wink. Three months after surgery, rectal manometry showed reg-
ular eﬃciency of the anal sphincter. Eighteen months after the
colostomy, a colostomy reversal was performed; the patient had an
uneventful postoperative course and was discharged 4 days later in
good clinical condition and with complete continence of stools.
Case 3
Patient 3 was a boy with Down syndrome, aged 4.8 years,
who was diagnosed with ALL at the age of 2.7 years and sub-
sequently treated according to the BFM ALL 2000 trial protocol.5
After several episodes of febrile neutropenia with bacteremia, 25
months after the initial diagnosis of leukemia, an early bone mar-
row relapse was detected. Palliative chemotherapy with vincristine,
asparaginase, and prednisone was initiated. Four weeks later, the
patient presented with a painful perianal ulceration, febrile neu-
tropenia, and sepsis. PSA grew from blood cultures, but it was not
detected from swabs of the anal lesion. Antimicrobial treatment
with meropenem was switched to ceftazidime and gentamicin after
6 days to allow outpatient treatment for 15 days in total. Analgetic
treatment consisted of fentanyl, acetaminophen, and metamizole.
The anal ulceration was initially managed with daily cleansing
baths containing diluted povidone-iodine (Betadine). Because of
the nonhealing perianal wound, increasing purulent discharge, and
pain, a surgical wound debridement under general anesthesia was
performed 4 weeks later. Because of still progressing discomfort
and pain, a palliative loop sigmoid colostomy was performed 2
weeks later. The postoperative course was uncomplicated, and the
patient was discharged after 4 days in good clinical condition.
Approximately 2 months later, the patient presented with a pro-
lapse of the colostomy that was manually reduced. The patient died
7 days later due to leukemia.
DISCUSSION
PSA in immunocompromised children may cause
severe perianal sepsis with severe destructive skin and tissue
infection, including the anal sphincter, manifesting as EG3.
This is an opportunistic invasive infection with increased
morbidity and mortality by ancillary neutropenia.1 Con-
ventional therapies include antibiotic treatment and local
surgical therapies such as extensive debridement. Perform-
ing a protective colostomy in immunocompromised
patients with EG must be considered, when local debride-
ments and wound care are not eﬃcient enough to allow
wound healing to occur, and particularly when the analT
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sphincter could be irreversibly damaged. Of note, it was
shown to be eﬀective in children with deep perianal burns.6
Chemotherapy and malnutrition may damage the
mucosa in immunocompromised patients. Oropharyngeal
and/or gastrointestinal bacterial translocation, referred to as
endogenous bacteremia, as well as invasive necrotizing tissue
infection may follow. From gastrointestinal colonization,
promoted by antimicrobial pretreatment, PSA may invade
the perianal region causing serious skin infections.3 Among
others, EG refers to a skin manifestation of pseudomonas
infection that arises especially in immunocompromised
patients.7 Usually, EG manifests ﬁrst as painless and
enlarging macules becoming heightened papules and ﬁnally
forming hemorrhagic bullae. After rupturing, these bullae
evolve into gangrenous ulcers encircled by reddened skin.3
Infection with PSA in immunocompromised patients often
follows neutropenia that represents a signiﬁcant prognostic
factor.2 Even when similar lesions are described by other
gram-negative bacteria, including Aeromonas hydrophila and
Klebsiella pneumoniae, as well as gram-positive bacteria
(Staphylococcus aureus and Streptococcus pyogenes), fungi, or
herpes simplex virus,3,8 it is essential to early recognize and
eﬀectively treat pseudomonas-related skin infections with
targeted antibiotics in the immunocompromised host.
Colostomies in the pediatric population may be per-
formed for diﬀerent purposes, including anorectal malfor-
mations and severe perianal burns.6 They are mainly used
to protect the distal colorectal tract from bacterial overload
and from distention.9 The diﬀerent types of colostomies all
have speciﬁc advantages and disadvantages. In loop
colostomies, a bowel loop is pulled out and sutured to the
abdominal wall, and 2 bowel openings are created, ending
in a single stoma. The intestinal wall continuity is thereby
partially preserved. Many (pediatric) surgeons use this
technique, especially in emergency settings, as loop colos-
tomies may be placed and reverted quickly.10 Another type
of colostomy that is typically performed in adult patients
with perforated diverticulitis is the Hartmann procedure or
end colostomy. Hereby, the involved sigmoid colon is
resected and the proximal end is pulled out and sutured to
the abdominal wall, whereas the distal/rectal stump is
closed and left in the abdomen. Stoma reversal may be
performed at a later stage.11,12 A disadvantage of this
technique is the loss of access for contrast studies and
anterograde lavages. In contrast, the procedure may be
performed quickly, the surgeon must create only 1 stoma,
and stool cannot ﬂow into the distal part.9 A third type of
colostomy is the double-barrel colostomy. Hereby, the
intestine is completely divided, and both bowel ends are
pulled out of the abdomen, creating 2 separate stomas.
While a larger opening for the proximal bowel ending is
created to enable stool passage, usually only a small mucus
ﬁstula is created at the distal ending. This enables contrast
studies and anterograde enemas but (in comparison with
end colostomies) increases the risk of a prolapse, which
mainly occurs at the mobile portions of the colon. In sit-
uations where the distal colonic part should be protected
from stool passage, such as in anorectal malformations,13
but deﬁnitely also in patients with severe, nonhealing per-
ianal skin lesions,1 the 2 stomas should be separated, which
FIGURE 1. A, Typical clinical features of ecthyma gangrenosum. B, After 16 days, a first local debridement had to be performed. C,
Because of a massive progression of the perianal lesion, a dismembered colostomy was performed. D, Soon after, the patient showed
progressive perianal healing.
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is referred to as a diverting colostomy (or dismembered
colostomy). This allows only the proximal stoma to be
covered with the stoma bag and prevents the mucus ﬁstula
from stool contamination.9 For all stoma types, complica-
tions include prolapse, dehiscence, infection, parastomal
hernia, retraction, and obstruction. In comparison with
double-barrel colostomies, loop colostomies present a
higher risk for prolapse formation.10,14
In the present study, 3 diﬀerent colostomies were
performed. Whereas the ﬁrst patient was treated with a
diverting double-barrel colostomy, the second patient was
treated with a nondiverting double-barrel colostomy.
Therefore, it is not surprising that patient 2 showed stool
passage into the distal portion of the colon that was ﬁrst
noted 6 months after surgery. In patient 3, a loop colos-
tomy was performed. Two months following the operation,
this patient presented with stoma prolapse that was easily
treated with manual reposition. All ostomies of this report
were placed through open technique. On the basis of sur-
geons’ experience, laparoscopic ostomy may oﬀer less per-
istomal hernia and/or wound dehiscence risk. Routine
barium enemas were performed in patients 1 and 2 prior
stoma reversal showing unaﬀected distal colorectal tracts.
Table 2 gives an overview of the literature. Of the 7
previously reported immunocompromised children with per-
ianal skin lesions treated with colostomy, 3 were treated with
diverting colostomies, 2 patients with complete anal sphincter
loss had end colostomies, and 2 had sigmoid colostomies
without further description of the operative procedure. In all
known patients (including the 7 patients depicted in the lit-
erature and the 3 patients described in the present report), no
major complications and no stoma-related deaths occurred.
This indicates that protective colostomy represents a valuable
strategy in the management of EG in immunocompromised
children. It results in rapid release of defecation-associated
pain and prompt wound healing because of the very sub-
stantial bacterial load reduction.
In conclusion, based on the literature quoted above
and in view of our own experience, diverting colostomy as
performed in 4 of the reported 10 patients (including ours),
seems to be the best option when an untractable perianal
and endoanal EG is present. It is easy to create and has a
low complication rate. It instantly guarantees a stool-free
colorectum, allows for painless antegrade cleansing enemas,
and leads to rapid and complete healing of the lesion.
Clearly, such a dismembered colostomy must be placed
before signiﬁcant anal sphincter destruction has occurred.
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